What is peripheral neuropathy, particularly in older adults with a history of diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Peripheral Neuropathy?

Peripheral neuropathy is damage to the peripheral nerves that causes sensory, motor, and autonomic dysfunction, most commonly presenting as a symmetric, length-dependent process affecting the feet first with symptoms of numbness, tingling, burning pain, or loss of protective sensation. 1

Definition and Epidemiology

Peripheral neuropathy affects approximately 1% of adults worldwide, increasing to 7% in those over 65 years of age. 1, 2 In older adults with diabetes, the prevalence is substantially higher—10-15% of newly diagnosed type 2 diabetes patients have diabetic peripheral neuropathy (DPN), and this increases to over 50% in those with diabetes duration exceeding 10 years. 3

Diabetic neuropathy is the most common cause of peripheral neuropathy in Western populations, accounting for more than 50% of cases. 1 This is particularly relevant for older adults with diabetes, where neuropathy represents a heterogeneous group of disorders with diverse clinical manifestations. 4

Clinical Presentation

Sensory Symptoms (Small Fiber Involvement)

The earliest and most common symptoms result from small nerve fiber damage and include: 4, 5

  • Burning pain described as constant or intermittent
  • "Electrical shock" sensations or stabbing, knife-like pains
  • Dysesthesias (unpleasant tingling sensations)
  • Altered temperature perception—feet feeling abnormally hot or cold, or experiencing heat sensation after cold exposure
  • Allodynia—pain from normally non-painful stimuli like clothing touching the skin 5
  • Pain characteristically worse at night, often causing sleep disturbance 5

Patients may describe discomfort as "walking barefoot on marbles" or "walking barefoot on hot sand." 5

Large Fiber Involvement

As neuropathy progresses to involve large myelinated fibers, patients develop: 4, 6

  • Numbness and loss of protective sensation (LOPS)
  • Loss of proprioception leading to balance problems
  • Decreased or absent reflexes in the lower extremities
  • Ataxia with difficulty walking and positive Romberg sign 6
  • Vibration sense loss

Critical Clinical Feature: Asymptomatic Neuropathy

Up to 50% of diabetic peripheral neuropathy may be completely asymptomatic. 4, 6 This is a dangerous situation because without recognition and preventive foot care, these patients are at high risk for injuries, diabetic foot ulcers, and amputations. 4 The absence of symptoms does not exclude significant nerve damage. 4

Pattern of Involvement

Peripheral neuropathy is typically: 1

  • Length-dependent—symptoms begin in the toes and progress proximally over time in a "stocking and glove" distribution
  • Symmetric—affecting both sides equally (asymmetric symptoms should prompt investigation for other causes) 5
  • Predominantly sensory—affecting sensory axons more than motor axons initially

Pathophysiology in Diabetic Patients

In diabetes, the pathogenesis involves multiple interconnected mechanisms: 3

  • Hyperglycemia-induced oxidative stress damaging nerve axons
  • Microvascular damage impairing nerve blood supply
  • Abnormal insulin signaling inhibiting neural repair and promoting apoptosis
  • Metabolic derangements including lipid metabolism disorders
  • Neuroinflammation and mitochondrial dysfunction

These processes disrupt the normal structure and function of myelinated and unmyelinated nerve axons, perikaryon, neurovascular structures, and glial cells. 3

Clinical Consequences and Complications

Foot Ulceration Risk

Peripheral sensory neuropathy is the single most common component cause for foot ulceration, present in 78% of diabetic patients with ulcers. 4 The triad of peripheral sensory neuropathy, minor trauma, and foot deformity is present in over 63% of patients with ulcerations. 4

The mechanism involves: 4

  • Loss of protective sensation allowing unrecognized trauma from ill-fitting shoes or walking barefoot
  • Foot deformities and limited joint mobility causing abnormal biomechanical loading
  • High-pressure areas leading to callus formation, subcutaneous hemorrhage, and eventual ulceration
  • Continued walking on insensitive feet impairing wound healing

Autonomic Neuropathy

Diabetic neuropathy can also affect autonomic nerves, causing: 4

  • Orthostatic hypotension and resting tachycardia
  • Gastroparesis with nausea, vomiting, and early satiety
  • Genitourinary disturbances including erectile dysfunction, retrograde ejaculation, bladder dysfunction, and female sexual dysfunction
  • Dry, cracked skin in the extremities due to impaired sweating

Impact on Quality of Life

Neuropathic pain profoundly impacts quality of life: 5

  • Severe sleep disturbance leading to fatigue and reduced daily activities
  • Depression and anxiety affecting over two-thirds of patients with painful diabetic neuropathy
  • Limitations in daily activities and poor treatment satisfaction

Screening and Diagnosis

When to Screen

All people with type 2 diabetes should be assessed for diabetic peripheral neuropathy starting at diagnosis, and those with type 1 diabetes starting 5 years after diagnosis, with at least annual reassessment thereafter. 4

Clinical Assessment Components

Assessment should include: 4

  1. Careful history of symptoms (pain, burning, numbness, tingling)
  2. Small-fiber function testing: pinprick sensation and temperature perception on the dorsum of the foot
  3. Large-fiber function testing: vibration perception using a 128-Hz tuning fork and assessment of lower-extremity reflexes
  4. Protective sensation testing: 10-g monofilament testing annually to identify feet at risk for ulceration and amputation

Important Diagnostic Principle

Diabetic neuropathy is a diagnosis of exclusion. 4 Nondiabetic neuropathies may coexist in people with diabetes and may be treatable. Initial laboratory evaluation should include: 7, 1

  • Vitamin B12 with metabolites (methylmalonic acid ± homocysteine)—particularly important in older adults and those on metformin
  • Thyroid-stimulating hormone (TSH) to identify hypothyroidism
  • Serum protein electrophoresis with immunofixation to detect monoclonal gammopathies
  • Complete metabolic panel to assess for renal disease

Electrophysiological testing or neurologist referral is rarely needed except when clinical features are atypical or diagnosis is unclear. 4 Standard nerve conduction studies may be completely normal in small fiber neuropathy, as these tests only evaluate large myelinated fibers. 5

Common Pitfalls

  • Assuming absence of symptoms means absence of neuropathy—up to 50% of cases are asymptomatic 4
  • Failing to perform annual foot examinations—this is critical for preventing ulcers and amputations 4
  • Not investigating reversible causes—vitamin B12 deficiency, hypothyroidism, and monoclonal gammopathies are treatable 7
  • Expecting complete reversal with treatment—even with optimal management, complete reversal of nerve damage is uncommon 1

References

Research

Peripheral neuropathies.

Handbook of clinical neurology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Peripheral Neuropathy and Neuropathic Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diabetic Neuropathy Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Idiopathic Peripheral Neuropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.